CNBC-TV18(@CNBCTV18Live) 's Twitter Profile Photo

signs licensing & supply agreement with Brazil-based Biomm for commercialisation of Semaglutide (gOzempic), which is used to improve glycemic control in adults with type-2 Diabetes

#Biocon signs licensing & supply agreement with Brazil-based Biomm for commercialisation of Semaglutide (gOzempic), which is used to improve glycemic control in adults with type-2 Diabetes
account_circle
Equity Expertise(@sandeeprathi100) 's Twitter Profile Photo

⭐ Stock Market News ⭐

Company signs licensing & supply agreement with -based Biomm for commercialisation of Semaglutide.

Fitch affirms at 'BBB-'; outlook Stable.

Market sToWatch Marketindia

account_circle
NDTV Profit(@NDTVProfitIndia) 's Twitter Profile Photo

signs pact for generic Ozempic (Semaglutide) commercialisation in Brazil with Biomm S.A.: Exchange Filing

For the latest news and updates, visit: ndtvprofit.com

account_circle
Bhagirath Sutariya(@Bhagirathsutar) 's Twitter Profile Photo

This is 𝗕𝗶𝗼𝗰𝗼𝗻 looks like ITC

जब ITC 2022 मे 200 पर trade कर रहा था तब अभी बायोकॉन के chart जैसा दिख रहा था.

✴️ Biocon could become the next ITC in next 2 years.

**This is my personal view, not buy or sell recommendation 🙏

This is 𝗕𝗶𝗼𝗰𝗼𝗻 looks like ITC 

जब ITC  2022 मे 200 पर trade कर रहा था तब अभी बायोकॉन के chart जैसा दिख रहा था.

✴️ Biocon could become the next ITC in next 2 years. 

**This is my personal view, not buy or sell recommendation 🙏
account_circle
AoI Ventures(@aoiventures) 's Twitter Profile Photo

signs an exclusive licensing and supply agreement for generic Ozempic (Semaglutide) commercialization in Brazil with Biomm S.A.

#Biocon signs an exclusive licensing and supply agreement for generic Ozempic (Semaglutide) commercialization in Brazil with Biomm S.A.
account_circle
The Wealth Creator Company(@wealth_creator9) 's Twitter Profile Photo

Top 20 high gain high volume stocks. This is not a recommendation.

1) Vedanta
2) NMDC Steel
3) Federal Bank
4) BHEL
5) Petronet LNG
6) Sundaram Multi Pap
7) Shree Renuka Sugars
8) NLC India
9) Coal India
10) Biocon
11) HPCL
12) Zee Entertainment Enterprises
13) GMDC
14)…

account_circle
Tactic Market Updates(@Tactic_market) 's Twitter Profile Photo

Biocon's Q4 Net Profit Slips

Biocon's Q4 net profit likely to decline by 192.8% to Rs 67.1 crore, with a 3.5% rise in net sales to Rs 3,730.4 crore and an 8% decrease in Q3FY24 EBITDA to Rs 623 crore.

account_circle
Biocon(@Bioconlimited) 's Twitter Profile Photo

: Biocon Limited signs an exclusive licensing & supply agreement for generic Ozempic (Semaglutide) commercialization in Brazil with Biomm S.A., a specialty pharmaceutical company in Brazil.

Siddharth Mittal, CEO & MD, Biocon Ltd, said, “Our partnership with Biomm marks another…

#Press: Biocon Limited signs an exclusive licensing & supply agreement for generic Ozempic (Semaglutide) commercialization in Brazil with Biomm S.A., a specialty pharmaceutical company in Brazil.

@sidmittal, CEO & MD, Biocon Ltd, said, “Our partnership with Biomm marks another…
account_circle